• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Bristol-Myers Squibb (NY:BMY)

    46.81 +0.06 (+0.13%)
    Streaming Delayed Price Updated: 12:44 PM EDT, May 19, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 3,525,662
    Open 46.60
    Bid (Size) 46.80 (3)
    Ask (Size) 46.81 (3)
    Prev. Close 46.75
    Today's Range 46.39 - 47.09
    52wk Range 39.35 - 63.30
    Shares Outstanding 2,222,113,553
    Dividend Yield 5.30%
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Options Corner: Political Turmoil Sets Up A Contrarian Call Spread For Bristol-Myers Squibb
    Although the Trump administration's healthcare policies pose risks for Bristol-Myers Squibb, the chaos opens a contrarian door for BMY stock. 
    Via Benzinga
    Topics Government
    Exposures Political
    3 Stocks That Will Profit From Trump's Drug Price Cut
    Trump's EO aims to lower US drug prices by using leverage of public programs (like Medicare) to force accountability. Big pharma may be hit hardest. 
    Via Benzinga
    Topics Government
    Exposures Political

    Performance

    YTD
    -17.6%
    -17.6%
    1 Month
    -4.4%
    -4.4%
    3 Month
    -14.0%
    -14.0%
    6 Month
    -17.6%
    -17.6%
    1 Year
    +8.0%
    +8.0%

    More News

    Read More
    Bristol Myers Squibb Receives European Commission Approval for Perioperative Regimen of Neoadjuvant Opdivo® (nivolumab) and Chemotherapy Followed by Adjuvant Opdivo for Resectable, High-Risk Non-Small Cell Lung Cancer with PD-L1 Expression ≥1%
    From Bristol Myers Squibb
    Via Business Wire
    BRISTOL-MYERS SQUIBB CO (NYSE:BMY) - A High-Yield Dividend Stock Worth Considering
    Via Chartmill
    What's going on in today's session: S&P500 movers
    Via Chartmill
    What Most-Favored-Nation Status Could Mean for Pharmaceutical Stocks
    Via The Motley Fool
    Topics Economy Government
    Exposures Interest Rates Political
    Stay informed with the top movers within the S&P500 index on Wednesday.
    Via Chartmill
    Sanofi To Navigate Tariff Impact With $20 Billion In Spending Through 2030
    Via Benzinga
    CMS Expands Medicare Drug Price Talks To Part B Meds In 2026 Shake Up
    Via Benzinga
    Bristol-Myers Squibb Strikes $350 Million Deal To End Hawaii's Plavix Lawsuit
    Via Benzinga
    Topics Lawsuit
    Exposures Financial Legal
    Top Biotech Halozyme Undercuts Its Breakout On Bad Medicare News
    Via Investor's Business Daily
    Topics Economy Government
    Exposures Interest Rates Political
    Market Monitor News May 12 ( NRG Energy, Amazon, Meta Platforms UP - CVS Health DOWN)
    Via Chartmill
    Topics Government World Trade
    Exposures Political Tariff
    Merck, Pfizer, Eli Lilly Stocks Rebound As Trump Targets Drug Costs With New Executive Order
    Via Stocktwits
    Topics Government
    Exposures Political
    S&P 500, Dow Jones Pharma Stocks Boomerang As Trump Threatens Drug-Price Reform
    Via Investor's Business Daily
    Topics Government Stocks
    Exposures Political US Equities
    EXCLUSIVE: FDA Clears Lantern Pharma's Planned Phase 1b/2 Trial of LP-184 In Treatment-Resistant Lung Cancer Patients
    Via Benzinga
    Exposures Product Safety
    Cathie Wood Says AI Innovation In Healthcare Will Be More 'Profound' Than Autonomous Taxi Networks, Humanoid Robots
    Via Benzinga
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    BMY Q1 Earnings Call: Growth Portfolio Offsets Declines, Guidance Raised Amid Pipeline Advancements
    Via StockStory
    Trump's New Drug Pricing Executive Order Could Rattle Pharma Stocks, With Price Cuts Of Up To 80%: Novo Nordisk, Pfizer And J&J Fall In Premarket
    Via Benzinga
    Topics Government
    Exposures Political
    BRISTOL-MYERS SQUIBB CO (NYSE:BMY) stands out as a stock that provides good value for the fundamentals it showcases.
    Via Chartmill
    3 Healthcare Stocks in Hot Water
    Via StockStory
    Topics Economy Stocks
    Exposures COVID-19 Supply Chain US Equities
    A Look Into Bristol-Myers Squibb Inc's Price Over Earnings
    Via Benzinga
    Top gainers and losers in the S&P500 index during Wednesday's after-hours session.
    Via Chartmill
    FDA Expands Surprise Inspections At Foreign Drug And Food Facilities, Targets Double Standards In Overseas Manufacturing Oversight
    Via Benzinga
    Exposures Product Safety
    Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields
    Via Benzinga
    Bristol Myers Squibb Appoints Cari Gallman as Executive Vice President, General Counsel and Chief Policy Officer
    From Bristol Myers Squibb
    Via Business Wire

    Frequently Asked Questions

    Is Bristol-Myers Squibb publicly traded?
    Yes, Bristol-Myers Squibb is publicly traded.
    What exchange does Bristol-Myers Squibb trade on?
    Bristol-Myers Squibb trades on the New York Stock Exchange
    What is the ticker symbol for Bristol-Myers Squibb?
    The ticker symbol for Bristol-Myers Squibb is BMY on the New York Stock Exchange
    What is the current price of Bristol-Myers Squibb?
    The current price of Bristol-Myers Squibb is 46.81
    When was Bristol-Myers Squibb last traded?
    The last trade of Bristol-Myers Squibb was at 05/19/25 12:44 PM ET
    What is the market capitalization of Bristol-Myers Squibb?
    The market capitalization of Bristol-Myers Squibb is 104.02B
    How many shares of Bristol-Myers Squibb are outstanding?
    Bristol-Myers Squibb has 104B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms Of Service.